Tags

Type your tag names separated by a space and hit enter

Extracorporeal magnetic innervation for the treatment of stress urinary incontinence: results of two-year follow-up.
Urol Int. 2008; 81(2):167-72.UI

Abstract

INTRODUCTION

Extracorporeal magnetic innervation (ExMI) is a relatively new technology used for pelvic muscle strengthening for the treatment of stress urinary incontinence. We aimed to evaluate the clinical efficacy of extracorporeal magnetic stimulation for the treatment of stress urinary incontinence.

MATERIALS AND METHODS

A total of 30 patients with demonstrable stress urinary incontinence were enrolled in this study. All were neurologically normal with normal urinalysis and none was pregnant. Evaluation before treatment included 3-day bladder diaries, a dynamic pad weight test, urodynamics, and a validated quality of life survey. Treatment sessions lasted 20 min, twice a week, for 6 weeks. After ExMI, all measures were repeated at follow-up including 3-day bladder diary, dynamic pad weight test, urodynamics and quality of life survey. The follow-up was done at 3, 12 and 24 months after ExMI therapy but urodynamics were performed only at first follow-up.

RESULTS

After ExMI therapy, 8 out of the 27 patients were cured (29.7%) and 13 patients were improved (48.1%) at 3 months. The cumulative success rate was 77.8%. Six patients did not show any improvement after treatment. Pad weight was reduced from 14.4 +/- 10.7 to 6.5 +/- 5.1 g. The mean score of quality of life survey at baseline was 61.6 and this increased to 75.4 at 12 weeks. The effect of ExMI approximately continued until the 1st year after therapy but gradually decreased and came close to baseline at the 2nd year after therapy.

CONCLUSION

As a result, ExMI therapy offers a new effective modality for pelvic floor muscle stimulation. ExMI also offers a noninvasive, effective and painless treatment for women with stress urinary incontinence. Further studies are needed to address how long the therapy will continue and benefits will last and whether retreatment or continuation therapy sessions will be necessary.

Authors+Show Affiliations

Department of Urology, Alanya Medical Center, Başent University, Antalya, Turkey. drburakhoscan@yahoo.comNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Evaluation Study
Journal Article

Language

eng

PubMed ID

18758214

Citation

Hoşcan, M B., et al. "Extracorporeal Magnetic Innervation for the Treatment of Stress Urinary Incontinence: Results of Two-year Follow-up." Urologia Internationalis, vol. 81, no. 2, 2008, pp. 167-72.
Hoşcan MB, Dilmen C, Perk H, et al. Extracorporeal magnetic innervation for the treatment of stress urinary incontinence: results of two-year follow-up. Urol Int. 2008;81(2):167-72.
Hoşcan, M. B., Dilmen, C., Perk, H., Soyupek, S., Armağan, A., Tükel, O., & Ekinci, M. (2008). Extracorporeal magnetic innervation for the treatment of stress urinary incontinence: results of two-year follow-up. Urologia Internationalis, 81(2), 167-72. https://doi.org/10.1159/000144055
Hoşcan MB, et al. Extracorporeal Magnetic Innervation for the Treatment of Stress Urinary Incontinence: Results of Two-year Follow-up. Urol Int. 2008;81(2):167-72. PubMed PMID: 18758214.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Extracorporeal magnetic innervation for the treatment of stress urinary incontinence: results of two-year follow-up. AU - Hoşcan,M B, AU - Dilmen,C, AU - Perk,H, AU - Soyupek,S, AU - Armağan,A, AU - Tükel,O, AU - Ekinci,M, Y1 - 2008/08/29/ PY - 2006/09/27/received PY - 2007/06/06/accepted PY - 2008/9/2/pubmed PY - 2009/2/3/medline PY - 2008/9/2/entrez SP - 167 EP - 72 JF - Urologia internationalis JO - Urol. Int. VL - 81 IS - 2 N2 - INTRODUCTION: Extracorporeal magnetic innervation (ExMI) is a relatively new technology used for pelvic muscle strengthening for the treatment of stress urinary incontinence. We aimed to evaluate the clinical efficacy of extracorporeal magnetic stimulation for the treatment of stress urinary incontinence. MATERIALS AND METHODS: A total of 30 patients with demonstrable stress urinary incontinence were enrolled in this study. All were neurologically normal with normal urinalysis and none was pregnant. Evaluation before treatment included 3-day bladder diaries, a dynamic pad weight test, urodynamics, and a validated quality of life survey. Treatment sessions lasted 20 min, twice a week, for 6 weeks. After ExMI, all measures were repeated at follow-up including 3-day bladder diary, dynamic pad weight test, urodynamics and quality of life survey. The follow-up was done at 3, 12 and 24 months after ExMI therapy but urodynamics were performed only at first follow-up. RESULTS: After ExMI therapy, 8 out of the 27 patients were cured (29.7%) and 13 patients were improved (48.1%) at 3 months. The cumulative success rate was 77.8%. Six patients did not show any improvement after treatment. Pad weight was reduced from 14.4 +/- 10.7 to 6.5 +/- 5.1 g. The mean score of quality of life survey at baseline was 61.6 and this increased to 75.4 at 12 weeks. The effect of ExMI approximately continued until the 1st year after therapy but gradually decreased and came close to baseline at the 2nd year after therapy. CONCLUSION: As a result, ExMI therapy offers a new effective modality for pelvic floor muscle stimulation. ExMI also offers a noninvasive, effective and painless treatment for women with stress urinary incontinence. Further studies are needed to address how long the therapy will continue and benefits will last and whether retreatment or continuation therapy sessions will be necessary. SN - 1423-0399 UR - https://www.unboundmedicine.com/medline/citation/18758214/Extracorporeal_magnetic_innervation_for_the_treatment_of_stress_urinary_incontinence:_results_of_two_year_follow_up_ L2 - https://www.karger.com?DOI=10.1159/000144055 DB - PRIME DP - Unbound Medicine ER -